82 related articles for article (PubMed ID: 9288574)
1. Pioglitazone and metformin reverse insulin resistance induced by tumor necrosis factor-alpha in liver cells.
Solomon SS; Mishra SK; Cwik C; Rajanna B; Postlethwaite AE
Horm Metab Res; 1997 Aug; 29(8):379-82. PubMed ID: 9288574
[TBL] [Abstract][Full Text] [Related]
2. Differential regulation of insulin action and tumor necrosis factor alpha system activity by metformin.
Biarnés J; Fernández-Real JM; Fernández-Castañer M; del Mar García M; Soler J; Ricart W
Metabolism; 2005 Feb; 54(2):235-9. PubMed ID: 15690319
[TBL] [Abstract][Full Text] [Related]
3. Direct comparison among oral hypoglycemic agents and their association with insulin resistance evaluated by euglycemic hyperinsulinemic clamp: the 60's study.
Derosa G; Maffioli P; Salvadeo SA; Ferrari I; Gravina A; Mereu R; Palumbo I; D'Angelo A; Cicero AF
Metabolism; 2009 Aug; 58(8):1059-66. PubMed ID: 19394976
[TBL] [Abstract][Full Text] [Related]
4. Proteome of H-411E (liver) cells exposed to insulin and tumor necrosis factor-alpha: analysis of proteins involved in insulin resistance.
Solomon SS; Buss N; Shull J; Monnier S; Majumdar G; Wu J; Gerling IC
J Lab Clin Med; 2005 May; 145(5):275-83. PubMed ID: 15902099
[TBL] [Abstract][Full Text] [Related]
5. Mechanisms involved in tumor necrosis factor-alpha induction of insulin resistance and its reversal by thiazolidinedione(s).
Solomon SS; Usdan LS; Palazzolo MR
Am J Med Sci; 2001 Aug; 322(2):75-8. PubMed ID: 11523631
[TBL] [Abstract][Full Text] [Related]
6. Comparison of the effects of pioglitazone and metformin on hepatic and extra-hepatic insulin action in people with type 2 diabetes.
Basu R; Shah P; Basu A; Norby B; Dicke B; Chandramouli V; Cohen O; Landau BR; Rizza RA
Diabetes; 2008 Jan; 57(1):24-31. PubMed ID: 17914032
[TBL] [Abstract][Full Text] [Related]
7. Effects of pioglitazone on hepatic and peripheral insulin resistance in Wistar fatty rats.
Sugiyama Y; Shimura Y; Ikeda H
Arzneimittelforschung; 1990 Apr; 40(4):436-40. PubMed ID: 2192715
[TBL] [Abstract][Full Text] [Related]
8. Effects of pioglitazone on glucose and lipid metabolism in Wistar fatty rats.
Sugiyama Y; Taketomi S; Shimura Y; Ikeda H; Fujita T
Arzneimittelforschung; 1990 Mar; 40(3):263-7. PubMed ID: 2189419
[TBL] [Abstract][Full Text] [Related]
9. Effects of pioglitazone and metformin on intracellular lipid content in liver and skeletal muscle of individuals with type 2 diabetes mellitus.
Teranishi T; Ohara T; Maeda K; Zenibayashi M; Kouyama K; Hirota Y; Kawamitsu H; Fujii M; Sugimura K; Kasuga M
Metabolism; 2007 Oct; 56(10):1418-24. PubMed ID: 17884455
[TBL] [Abstract][Full Text] [Related]
10. Effect of thiazolidinediones and metformin on LDL oxidation and aortic endothelium relaxation in diabetic GK rats.
Iida KT; Kawakami Y; Suzuki M; Shimano H; Toyoshima H; Sone H; Shimada K; Iwama Y; Watanabe Y; Mokuno H; Kamata K; Yamada N
Am J Physiol Endocrinol Metab; 2003 Jun; 284(6):E1125-30. PubMed ID: 12569086
[TBL] [Abstract][Full Text] [Related]
11. Comparison of the effects of pioglitazone and metformin on insulin resistance and hormonal markers in patients with impaired glucose tolerance and early diabetes.
Eguchi K; Tomizawa H; Ishikawa J; Hoshide S; Numao T; Fukuda T; Shimada K; Kario K
Hypertens Res; 2007 Jan; 30(1):23-30. PubMed ID: 17460368
[TBL] [Abstract][Full Text] [Related]
12. Prevention of ethanol-induced liver injury in rats by an agonist of peroxisome proliferator-activated receptor-gamma, pioglitazone.
Enomoto N; Takei Y; Hirose M; Konno A; Shibuya T; Matsuyama S; Suzuki S; Kitamura KI; Sato N
J Pharmacol Exp Ther; 2003 Sep; 306(3):846-54. PubMed ID: 12805475
[TBL] [Abstract][Full Text] [Related]
13. Pioglitazone: mechanism of action.
Smith U
Int J Clin Pract Suppl; 2001 Sep; (121):13-8. PubMed ID: 11594239
[TBL] [Abstract][Full Text] [Related]
14. Metformin and pioglitazone: Effectively treating insulin resistance.
Staels B
Curr Med Res Opin; 2006; 22 Suppl 2():S27-37. PubMed ID: 16914073
[TBL] [Abstract][Full Text] [Related]
15. Metformin restores responses to insulin but not to growth hormone in Sprague-Dawley rats.
Borst SE; Snellen HG; Ross H; Scarpace PJ; Kim YW
Biochem Biophys Res Commun; 2002 Mar; 291(3):722-6. PubMed ID: 11855850
[TBL] [Abstract][Full Text] [Related]
16. The significance of tumor necrosis factor-alpha in newly diagnosed type 2 diabetic patients by transient intensive insulin treatment.
Chen H; Ren A; Hu S; Mo W; Xin X; Jia W
Diabetes Res Clin Pract; 2007 Mar; 75(3):327-32. PubMed ID: 16930761
[TBL] [Abstract][Full Text] [Related]
17. Effects of rosiglitazone and metformin on inflammatory markers and adipokines: decrease in interleukin-18 is an independent factor for the improvement of homeostasis model assessment-beta in type 2 diabetes mellitus.
Kim HJ; Kang ES; Kim DJ; Kim SH; Ahn CW; Cha BS; Nam M; Chung CH; Lee KW; Nam CM; Lee HC
Clin Endocrinol (Oxf); 2007 Feb; 66(2):282-9. PubMed ID: 17224000
[TBL] [Abstract][Full Text] [Related]
18. Promising new approaches.
Reasner CA
Diabetes Obes Metab; 1999 May; 1 Suppl 1():S41-8. PubMed ID: 11220287
[TBL] [Abstract][Full Text] [Related]
19. Neferine enhances insulin sensitivity in insulin resistant rats.
Pan Y; Cai B; Wang K; Wang S; Zhou S; Yu X; Xu B; Chen L
J Ethnopharmacol; 2009 Jul; 124(1):98-102. PubMed ID: 19527823
[TBL] [Abstract][Full Text] [Related]
20. Ameliorating effect of FK614, a novel nonthiazolidinedione peroxisome proliferator-activated receptor gamma agonist, on insulin resistance in Zucker fatty rat.
Minoura H; Takeshita S; Yamamoto T; Mabuchi M; Hirosumi J; Takakura S; Kawamura I; Seki J; Manda T; Ita M; Mutoh S
Eur J Pharmacol; 2005 Sep; 519(1-2):182-90. PubMed ID: 16039648
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
